AWR vs MGEE

AWR exhibits stable financial health with a Piotroski F-Score of 6/9, indicating moderate strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears fairly valued with a current price of $73.16 near the analyst target of $81.00 and intrinsic value estimate of $81.76, despite trading above the conservative Graham Number of $44.06. Solid profitability metrics—such as a 33.96% operating margin and 13.78% ROE—contrast with a bearish technical trend and weak insider sentiment. Revenue and earnings growth remain positive year-over-year, but recent quarterly volatility and limited analyst coverage warrant caution.

MGEE presents a dichotomy between superior operational efficiency and poor valuation metrics. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts profit margins and ROE significantly above sector averages, the stock is trading at a substantial premium to its Graham Number ($54.65) and Intrinsic Value ($54.50). The technical trend is currently bearish (0/100), and a consistent history of missing earnings estimates suggests limited near-term catalysts for price appreciation despite a conservative debt profile.